Role of Slit2/Robo1 in the Pathogenesis of Gastrointestinal Vascular Malformation and the Effect of Thalidomide on Their Expression

李一男,戈之铮,高云杰,冯倩,陈慧敏,房静远,萧树东
DOI: https://doi.org/10.13748/j.cnki.issn1007-7693.2013.04.023
2013-01-01
Abstract:OBJECTIVE To study the role of Slit2/Robo1 in the pathogenesis of gastrointestinal vascular malformation(GIVM) and the effect of thalidomide on their expression.METHODS We collected the biopsy specimens of 7 patients with GIVM including the vascular malformation region and normal mucosa region.The expression levels of vascular endothelial growth factor(VEGF),Slit2,Robo1 in patients tissues was measured by Western blot to find out the difference in the mucosa.Then cultured human umbilical vein endothelial cell(HUVEC) and intervened HUVEC with thalidomide of different concentration(50,100,200 mg.L 1) for 24 hours or 48 hours to observe the expression of VEGF,Slit2,Robo1 by real-time PCR and Western blot.RESULTS VEGF,Slit2,Robo1 was strongly expressed in all patients tissues with angiodysplasia lesions,as compared to expression in tissues without angiodysplasia lesions of the same patient.Thalidomide decreased VEGF,Slit2,Robo1 expression,both at the protein and mRNA levels in a dose-dependent manner.CONCLUSION Slit2/Robo1 may play an important role in the pathogenesis of angiodysplasia.Thalidomide can suppress VEGF,Slit2/Robo1 expression.This may be the mechanism of the therapeutic effect of thalidomide on GIVM.
What problem does this paper attempt to address?